Department of Health Policy & Management and Institute for Medical Technology Assessment, Erasmus University Rotterdam (iBMG/iMTA), P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands,
Pharmacoeconomics. 2014 Jan;32(1):75-86. doi: 10.1007/s40273-013-0110-1.
There is an increased interest in the monetary value of a quality-adjusted life-year (QALY). Past studies commonly derived willingness to pay (WTP) for certain future QALY gains. However, obtaining valid WTP per QALY estimates proved to be difficult.
We conducted a contingent valuation study and estimated the individual WTP per QALY under risk. We demonstrate the impact of probability weighting on WTP per QALY estimates in the Netherlands.
Our estimates of the value of a QALY are in the range of €80,000-110,000 when the weighting correction was applied, and €250,500 without correction. The validity of these estimates, applying probability weighting, appears to be good.
Given the reasonable support for their validity and practical meaningfulness, the estimates derived while correcting for probability weighting may provide valuable input for the debate on the consumption value of health. While decision makers should not apply these estimates without further consideration, since strictly individual valuations may not carry all relevant information and values for societal decision-making, the current estimates may provide a good and informed basis for further discussion and study of this important topic.
人们对质量调整生命年(QALY)的货币价值越来越感兴趣。过去的研究通常是针对某些未来 QALY 收益来得出支付意愿(WTP)。然而,获得有效的每 QALY 支付意愿估计值是很困难的。
我们进行了一项条件价值评估研究,并估计了风险下每 QALY 的个人支付意愿。我们展示了荷兰概率加权对每 QALY 支付意愿估计值的影响。
当应用权重修正时,我们对 QALY 价值的估计在 80,000 欧元至 110,000 欧元之间,而没有修正时则为 250,500 欧元。这些估计值的有效性,在应用概率加权时似乎是良好的。
鉴于对其有效性和实际意义的合理支持,在对概率加权进行修正后得出的估计值可能为健康消费价值的辩论提供有价值的参考。虽然决策者不应在没有进一步考虑的情况下应用这些估计值,因为严格的个人评估可能无法为社会决策提供所有相关的信息和价值,但目前的估计值可以为进一步讨论和研究这一重要主题提供一个良好的、有根据的基础。